News Stocks 

Portola stock shoots higher after FDA approval

“Portola shares had declined about 60% so far this year, as the S&P 500 index SPX, +0.85% has declined 7%” writes Jeremy C for PTLA, +14.22% shares jumped Monday after the company announced that the Food and Drug Administration had given an approval that should lead to the launch of its Andexxa drug.Portola’s stock was halted ahead of the news, then jumped about 13% after trading resumed at 3:40 p.m.

Related posts